We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+8.89%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$14.6B
AUM Growth
-$3.14B
Cap. Flow
-$4.13B
Cap. Flow %
-28.38%
Top 10 Hldgs %
20.74%
Holding
1,655
New
313
Increased
216
Reduced
349
Closed
770

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$214M
2
MDT icon
Medtronic
MDT
+$123M
3
CHTR icon
Charter Communications
CHTR
+$97.9M
4
MRK icon
Merck
MRK
+$94M
5
ZTS icon
Zoetis
ZTS
+$91.7M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$253M
2
BIDU icon
Baidu
BIDU
+$120M
3
STZ icon
Constellation Brands
STZ
+$110M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$104M
5
ABT icon
Abbott
ABT
+$98.2M

Sector Composition

Rank Sector Weight
1 Healthcare 31.1%
2 Technology 16.39%
3 Industrials 11.22%
4 Consumer Discretionary 9.86%
5 Financials 9.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIIB icon
51
Biogen
BIIB
$30.7B
$73.1M 0.5%
+206,768
New +$71.2M
TWOU
52
DELISTED
2U Inc
TWOU
$71.7M 0.49%
31,783
-5,824
-15% -$14.4M
TMUS icon
53
T-Mobile US
TMUS
$190B
$70.8M 0.49%
1,008,217
+272,139
+37% +$17.5M
GILD icon
54
Gilead Sciences
GILD
$165B
$70M 0.48%
+906,920
New +$68.5M
AAPL icon
55
Apple
AAPL
$4.57T
$69.6M 0.48%
1,233,420
-118,124
-9% -$6.15M
JPM icon
56
JPMorgan Chase
JPM
$950B
$69.2M 0.48%
613,062
+163,688
+36% +$18.6M
SAGE
57
DELISTED
Sage Therapeutics
SAGE
$69.1M 0.47%
489,148
-38,468
-7% -$5.94M
OLLI icon
58
Ollie's Bargain Outlet
OLLI
$4.94B
$67.9M 0.47%
707,041
– –
RTN
59
DELISTED
Raytheon Company
RTN
$63.8M 0.44%
308,931
+240,981
+355% +$48M
CVS icon
60
CVS Health
CVS
$122B
$61.7M 0.42%
783,805
+199,376
+34% +$14.3M
TRI icon
61
Thomson Reuters
TRI
$44.1B
$60.3M 0.41%
+1,137,610
New +$57M
PGR icon
62
Progressive
PGR
$125B
$59.9M 0.41%
843,284
-33,995
-4% -$2.19M
NBIX icon
63
Neurocrine Biosciences
NBIX
$16.6B
$58.5M 0.4%
475,440
-127,535
-21% -$14.5M
COR icon
64
Cencora
COR
$61.2B
$57.2M 0.39%
620,403
+454,154
+273% +$39.3M
BA icon
65
Boeing
BA
$185B
$56.7M 0.39%
152,565
+115,963
+317% +$40.7M
ALXN
66
DELISTED
Alexion Pharmaceuticals
ALXN
$55.5M 0.38%
399,292
-605,877
-60% -$76M
AGN
67
DELISTED
Allergan plc
AGN
$55.5M 0.38%
291,146
+179,280
+160% +$32.9M
AVGO icon
68
Broadcom
AVGO
$2.04T
$55.3M 0.38%
2,242,290
-1,115,180
-33% -$25M
RTX icon
69
RTX Corp
RTX
$301B
$54.9M 0.38%
624,062
-15,539
-2% -$1.3M
INTU icon
70
Intuit
INTU
$89B
$54.6M 0.38%
240,146
-51,063
-18% -$11M
TSM icon
71
TSMC
TSM
$2.18T
$54.2M 0.37%
1,228,073
+70,473
+6% +$2.92M
PX
72
DELISTED
Praxair Inc
PX
$53.9M 0.37%
335,557
-124,763
-27% -$20M
BMRN icon
73
BioMarin Pharmaceuticals
BMRN
$12.4B
$53.8M 0.37%
555,209
+257,073
+86% +$25.7M
UHS icon
74
Universal Health Services
UHS
$10.5B
$53.1M 0.36%
415,588
-145,395
-26% -$17.8M
ROL icon
75
Rollins
ROL
$18.2B
$51.9M 0.36%
+1,922,378
New +$49.6M
1 2
3
4 5

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q3 2018 Portfolio in Review

As of Q3 2018, Marshall Wace North America held 1,655 positions worth $14.6B, down 18% from $17.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Marshall Wace North America withdrew a net $4.13B in Q3 2018, closing 770 positions and reducing 349 holdings. Its most notable exit was Baidu, an estimated $120M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.

Against the trend, Marshall Wace North America opened a new position in Medtronic worth $130M.

  • Marshall Wace North America's largest Q3 2018 buy was Medtronic: 1,325,878 shares worth $130M.
  • Marshall Wace North America added most to Alphabet (Google) Class A in Q3 2018, an estimated $214M increase.
  • Marshall Wace North America's biggest Q3 2018 reduction was Meta Platforms (Facebook), cutting an estimated $253M.
  • Marshall Wace North America fully exited Baidu in Q3 2018, selling an estimated $120M.
  • Marshall Wace North America's ten largest holdings make up 21% of its $14.6B portfolio in Q3 2018.
  • Marshall Wace North America opened 313 new positions and closed 770 in Q3 2018.
  • Marshall Wace North America's portfolio value fell 18% quarter-over-quarter to $14.6B.

Based on Marshall Wace North America's 13F filing for Q3 2018, filed 14 Nov 2018.